Accueil › Cancer de l'endomètre › Virginie › Arlington
Essais cliniques pour Cancer de l'endomètre à Arlington, VA
39 études pour Cancer de l'endomètre recherchent des participants dans et autour de Arlington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Recrutement en coursPhase 2
- Inova Fairfax Hospital, Falls Church · à 4 mi
- Inova Schar Cancer Institute, Fairfax · à 11 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- NEXT Virginia, Fairfax · à 11 mi
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Recrutement en coursPhase 1
- Site 04, Fairfax · à 11 mi
Study of AVZO-021 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · à 11 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Recrutement en coursPhase 3
- Inova Schar Cancer Institute ( Site 6003), Fairfax · à 11 mi
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · à 11 mi
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Recrutement en coursPhase 1/2
- NEXT Oncology, Fairfax · à 11 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Recrutement en coursPhase 3
- Research Site, Fairfax · à 11 mi
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Inova Schar Cancer Institute, Falls Church · à 4 mi
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- Research Site, Fairfax · à 11 mi
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Recrutement en coursPhase 1
- Normunity Investigational Site, Fairfax · à 11 mi
A Study of PHST001 in Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - Virginia, Fairfax · à 11 mi
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · à 11 mi
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recrutement en coursPhase 1/2
- USOR Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Recrutement en coursPhase 3
- Research Site, Falls Church · à 4 mi
- Research Site, Fairfax · à 11 mi
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Recrutement en coursPhase 2
- 522, Fairfax · à 11 mi
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · à 11 mi
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- NEXT, Fairfax · à 11 mi
A Study of LY4175408 in Participants With Advanced Cancer
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Recrutement en coursPhase 1
- NEXT Texas LLC - Virginia, Fairfax · à 11 mi
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Recrutement en coursPhase 1
- Dren Investigational Site, Fairfax · à 11 mi
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Recrutement en coursPhase 2
- Virginia Cancer Specialists, P.C., Fairfax · à 11 mi
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Essais pour Cancer de l'endomètre dans d'autres villes
- Houston, TX68 études
- New York City, NY52 études
- Boston, MA50 études
- Nashville, TN38 études
- Los Angeles, CA34 études
- St. Louis, MO29 études
- Philadelphia, PA28 études
- San Antonio, TX27 études
- Chicago, IL25 études
- Columbus, OH25 études
- Queens, NY25 études
- Oklahoma City, OK25 études
Autres études à Arlington
- Cancer du poumon non à petites cellules104 études
- Cancer métastatique53 études
- Cancer colorectal52 études
- Cancer (tous types)48 études
- Cancer du sein46 études
- Cancer de l'ovaire46 études
- Cancer du poumon41 études
- Cancer du pancréas33 études
- Carcinome épidermoïde de la tête et du cou26 études
- Cancer bronchique à petites cellules23 études
- Cancer du sein triple négatif20 études
- Cancer de l'estomac20 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.